The International Centre for Diffraction Data
汉语
Español
Deutsch
Français
Italiano
日本語
Português
русский язык
Home
About
Contact
Sitemap
HOME
About ICDD
About ICDD Home
Latest News
ICDD Overview
ICDD Exhibitions
ICDD Calendars
Mission Statements
Board of Directors
Staff
Jobs
Location
2010 ICDD Meeting
ICDD Newsletters
Products
Products Home
Licensing
E-store
Distributors
Products Overview
PDF-4+
WebPDF-4+
PDF-4/Minerals
PDF-4/Organics
PDF-4 Support Software
PDF-2
PDF-2 Support Software
Powder Diffraction
Journal
Hot Tips
Product References
Multiyear Licensing
Site Licensing
Conversion Pricing
Pricing Policies
Customer Service
Membership
Membership Home
Become A Member
Active Members
Associate Members
Student Affiliates
Fellows
Distinguished Fellows
Technical Subcommittees
Register to TechCom
TechCom Minutes
Members Only Area
Education
Education Home
PPXRD Symposium
Clinics Home
XRD Clinic
XRF Clinic
Tuition Waivers
Workshops
Specimen Preparation for X-ray Fluorescence Workshop
Rietveld Refinement & Indexing Workshop
PDF Users Meeting
On-site Training Solutions
GiA
Grant-in-Aid Home
Grant-in-Aid Guidelines
Grant-in-Aid Recipients
Resources
Resources Home
Advances in X-ray Analysis
Product References
Product Support
Hot Tips
Request for Financial Support
Awards and Scholarships
Powder Diffraction Data Submission
Links
Developers
Developers Home
DXC
Denver X-ray Conference Home
2010 DXC
Advances in X-ray Analysis
Search
Search Home
Table of Contents
Home
Research Tools
Browse PPXRD
PPXRD-9
PPXRD-8
PPXRD-7
PPXRD-6
PPXRD-5
PPXRD-4
PPXRD-3
PPXRD-2
Search PPXRD 2-9 Abstracts
Browse PPXRD Abstract Titles
SELECT TITLE
α AND β LACTOSE: AB INITIO INDEXING AND STRUCTURAL DETERMINA
21CFR PART11 - WHAT\'S LEFT (FOR XRPD)?
A NEW HIGH PERFORMANCE HIGH-RESOLUTION POWDER DIFFRACTION SYSTEM AND I
A NEW HIGH-THROUGHPUT SAXS SCREENING TOOL FOR ACCELERATED COMBINATORIA
A NOVEL APPROACH OF USING POWDER X-RAY DIFFRACTION FOR HIGH-THROUGHPUT
A PATENT PRIMER FOR THE PHARMACEUTICAL SCIENTIST
A UNIQUE CASE OF POLYMORPH CHARACTERIZATION BY PXRD
AB INITIO CRYSTAL STRUCTURE DETERMINATION OF TWO POLYMORPHIC MODIFICAT
ACCURACY IN POWDER DIFFRACTION MEASUREMENTS
ACCURATE POWDER STRUCTURAL STUDY OF PHARMACEUTICALS USING MAXIMUM ENTR
ADVANCED XRPD SYSTEM FOR THE CHARACTERIZATION OF PHARMACEUTICAL COMPOU
ADVANCES IN CRYSTAL STRUCTURE SOLUTION BY EXPO2008
ADVANCES IN INDEXING OF POWDER DIFFRACTION PATTERNS: ITERATIVE USE OF
ADVANCES IN INDEXING OF POWDER DIFFRACTION PATTERNS: ITERATIVE USE OF
AN INTEGRATED SYSTEM FOR SOLVENT SOLUBILITY, SINGLE CRYSTAL GROWING, A
AN OVERVIEW OF METHODS AND STRATEGIES FOR HIGH-THROUGHPUT POLYMORPH SC
ANALYSES OF PHARMACEUTICAL FORMULATIONS
ANALYSIS OF AMORPHOUS PHASE IN HIGHLY CRYSTALLINE API BY POWDER X-RAY
ANALYSIS OF BLISTER PACKED TABLETS
ANALYSIS OF MANNITOL X-RAY DIFFRACTION PATTERNS
ANALYSIS OF SHORT RANGE ORDER IN X-RAY AMORPHOUS INDOMETHACIN USING X-
APPLICATION OF HIGH THROUGHPUT SCREENING TO THE STUDY OF THE CONFORMAT
APPLICATION OF HIGH-THROUGHPUT CLUSTER ANALYSIS TO MULTIPLE DATA TYPE
APPLICATION OF X-RAY SPECTROMETRY AT X-RAY ABSORPTION EDGES FOR INVEST
APPLICATION OF XRD IN POLYMORPH IDENTIFICATION DURING HIGH THROUGHPUT
APPLICATIONS OF X-RAY POWDER DIFFRACTION TO HIGH THROUGHPUT DISCOVERY
APPLICATIONS OF X-RAY POWDER DIFFRACTION TO REGULATORY ISSUES
APPLICATIONS OF X-RAY POWER DIFFRACTION IN PHARMACEUTICAL
AUTOMATED ANALYIS OF POWDER X-RAY DATA USING SCRIPTING AND DATA PIPELI
AUTOMATIC PROCESSING AND PERFORMANCE QUALIFICATION (PQ) IN PHARMACEUTI
AUTOMATION OF XRPD DATA ACQUISITION AND PATTERN ANALYSIS
AUTOMATION PLATFORM FOR SALT PRESCREENING AND POLYMORPH SCREENING STUD
AUTOMATION SOLUTIONS FOR SALT PRESCREENING AND POLYMORPH SCREENING STU
BUILDING A STRONG PATENT PORTFOLIO WITH COCRYSTALS AND DISORDERED SOLI
CHALLENGES IN DETECTING CRYSTALLINE PHASE IN AN AMORPHOUS MATRIX
CHARACTERISATION AND PREDICTION OF STABILITY OF AMORPHOUS MATERIALS DU
CHARACTERIZATION OF INSULIN MICROCRYSTALS IN PHARMACEUTICAL SUSPENSION
CHARACTERIZATION OF INTACT PHARMACEUTICAL FILM-COATED TABLETS BY MICRO
CHARACTERIZATION OF PHARMACEUTICALS BY XRPD AND THERMAL ANALYSIS: BUPR
CHARACTERIZATION OF THE ACTIVE PHARMACEUTICAL INGREDIENT IN FILM-COATE
CHARACTERIZATION OF THE PHYSICAL FORM OF THE ACTIVE PHARMACEUTICAL ING
CHARGE-FLIPPING STRUCTURE SOLUTION FROM SINGLE CRYSTAL AND POWDER DIFF
CHEMOMETRICS AS A TOOL FOR COMPARING DIFFERENT GEOMETRICAL MODES IN MU
CHIRAL SYMMETRY BREAKING IN THE CRYSTALLIZATION OF 1,1\' BINAPHTYL AND
CLOSE CONTACT PENALTY FUNCTIONS IN DIRECT SPACE METHODS AND ENERGETIC
CLOSE CONTACT PENALTY FUNCTIONS IN DIRECT SPACE METHODS AND ENERGETIC
CLOSE CONTACT PENALTY FUNCTIONS IN DIRECT SPACE METHODS AND ENERGETIC
COMBINED XRD AND RAMAN COMBINATORIAL SCREENING
COMBINED XRD AND RAMAN COMBINATORIAL SCREENING SYSTEM
COMBINING MICRO X-RAY FLUORESCENCE AND INFRARED IMAGING SPECTROSCOPIES
COMPARISON OF SPECIMEN PREPARATION TECHNIQUES FOR X-RAY POWDER DIFFRAC
COMPLEMENTARY TECHNIQUES FORTHE CHARACTERIZATION OF PHARMACEUTICAL SYS
COMPUTED CRYSTAL ENERGY LANDSCAPES AS AN AID TO UNDERSTANDING POLYMORP
CONVOLUTION BASED PROFILE FITTING
CRYSTAL STRUCTURE DETERMINATION FROM POWDER X-RAY DIFFRACTION DATA
CRYSTAL STRUCTURE DETERMINATION FROM SYNCHROTRON X-RAY POWDER DIFFRACT
CRYSTAL STRUCTURE OF Δ-MANNITOL
CRYSTAL STRUCTURE OF D-MANNITOL HEMIHYDRATE
CRYSTAL STRUCTURE SOLUTION AND REFINEMENT OF A SERIES OF D
2
CRYSTAL STRUCTURES AND BONDING IN CELLULOSE POLYMORPHS
CRYSTAL STRUCTURES OF PHARMACEUTICALLY ACCEPTABLE CARBAMAZEPINE COCRYS
CRYSTALLITE SIZES AND MICROSTRAINS DETERMINED BY RIETVELD REFINEMENT:
CRYSTALLITE VOLUME, AREA, SPECIFIC AREA AND MORPHOLOGY OBTAINED VIA RI
CRYSTALLIZATION OF LYOPROTECTANT IN THE FROZEN SYSTEM AND ITS PHASE TR
CRYSTALS STRUCTURES OF MODERATLY COMPLEX ORGANIC MOLECULES ARE PREDICT
DEHYDRATION AND RE-HYDRATION OF TREHALOSE STUDIED BY HUMIDITY CONTROLL
DETERMINATION OF CRYSTALLIZATION OF AMORPHOUS INDOMETHACIN (IMC) IN CO
DETERMINATION OF SPECIFIC SURFACE AND PARTICLE SIZE DISTRIBUTION BY SM
DETERMINATION OF THE EUTECTIC TEMPERATURE OF TREHALOSE-WATER BINARY SY
DETERMINING THE RELATIVE SENSITIVITY OF X-RAY POWDER DIFFRACTION FOR I
DEVELOPING POWDER X-RAY DIFFRACTION (XRD) QUANTITATIVE METHOD FOR OROS
DEVELOPMENT OF COMPACT, LOW-POWER, IN-SITU DIFFRACTION-BASED ANALYZERS
DIFFRACTION, NON-CRYSTALLINITY, AND THE PDF DATABASE
DO \'STANDARD\' DIRECT METHODS STILL HAVE A ROLE TO PLAY IN XRPD STRUC
DRUG PRODUCT CHARACTERIZATION: WHAT FORM DO I HAVE?
EASY ACCESS TO SYNCHROTRON POWDER DIFFRACTION FOR PHARMACEUTICALS
EDXRD PROBE FOR PHAMACEUTICAL VERIFICATION
EFFECT OF HIGH HYDROSTATIC PRESSURE ON THE GAMMA-POLYMORPH OF GLYCINE:
ENVIRONMENTAL ATOMIC FORCE AND CONFOCAL RAMAN MICROSCOPIES IN PHARMACE
EQUIPMENT QUALIFICATION
EXAMPLES OF COMPLEMENTARY STUDIES OF THE METASTABLE POLYMORPHS OF PHAR
EXPLORING POLYMORPHISM OF MOLECULAR MATERIALS USING HIGH PRESSURE - OP
FORMULATION ANALYSES OF COMMON HEALTH SUPPLEMENTS
FORMULATION ANALYSES OF OFF THE SHELF PHARMACEUTICALS
GASTRORETENTIVE DRUG DELIVERY SYSTEM OF CARBAMAZEPINE:FORMULATION OPTI
GENERATION OF ACCURATE X-RAY POWDER DIFFRACTION DATA OF A PHARMACEUTIC
GEOMETRY AND CONFIGURATION OF XRD SYSTEMS FOR PHARMACEUTICAL
GEOMETRY, POLARIZATION AND ABSORPTION CORRECTIONS FOR TWO-DIMENSIONAL
HIGH RESOLUTION, HIGH THROUGHPUT X-RAY POWDER DIFFRACTION (HR HT XRPD)
HIGH THROUGHPUT ANALYSIS OF STRUCTURAL GEOMETRIES MINED FROM THE CSD:
HIGH THROUGHPUT SCREENING: DIFFRACTION ANALYSIS OF BRAND NAME DRUGS AN
HIGH-THROUGHPUT POWDER DIFFRACTION - THE SEARCH FOR POLYMORPHS
HIGH-THROUGHPUT SCREENING IN SOLD FORM SELECTION
HIGH-THROUGHPUT STRUCTURE DETERMINATION, HIGH-QUALITY STRUCTURE REFINE
HOW HIGH-RESOLUTION X-RAY POWDER DIFFRACTION SHOULD HELP THE CONSTRUCT
HOW TO COMBINE PXRD, RAMAN AND OTHER 1-D DATA IN HIGH THROUGHPUT POLY
HYDRATES PRODUCED BY CONTROLLING WATER ACTIVITIES IN
IDENTIFICATION AND CRYSTAL STRUCTURE SOLUTION OF STABLE AND METASTABLE
IDENTIFICATION OF GUMS AND SCREENING FOR CATALYST RESIDUES IN PHARMACE
IDENTIFICATION OF POLYMORPH TYPE AND PREDICTION OF MATERIALS PROPERTIE
IN SITU XRPD OF COMPACTS AS A POTENTIAL NON-DESTRUCTIVE ANALYTICAL TEC
IN-SITU NANOSTRUCTURE MONITORING BY SMALL-AND WIDE-ANGLE X-RAY SCATTER
IN-SITU VARIABLE TEMPERATURE POWDER X-RAY DIFFRACTION AND THERMAL ANAL
INDEXING POWDER DIFFRACTION PATTERNS WITH THE DICHOTOMY ALGORITHM
INDEXING: ALGORITHMS, ACCURACY, AND AB INITIO
INFLUENCE OF EXPERIMENTAL CONDITIONS ON THE PHASE TRANSITIONS OF &ALP
INFLUENCE OF POWDER DIFFRACTOMETER GEOMETRY ON THE RESULTS OF STRUCTUR
INTEGRATED HYPERSPECTRAL IMAGING FOR COMPREHENSIVE MATERIALS CHARACTER
LAYERED STRUCTURE OF A MULTIPLE HYDRATE-FORMING PHARMACEUTICAL COMPOUN
LOD METHOD FOR THE DETECTION OF THE PRESENCE OF ONE POLYMORPHIC FORM I
LOWERING THE LIMITS OF DETECTION OF PHARMACEUTICAL MATERIALS BY POWDER
MANY PATTERNS AND MANY METHODS: NEW METHODS UTILISING MULTIPLE ANALYS
MAPPING DRUG CHEMISTRY USING CLUSTER ANALYSIS AND DIFFRACTION DATABASE
MATERIAL IDENTIFICATION: THE DESCRIPTIVE STATISTICS OF PHASE IDENTIFIC
MATERIALS CHARACTERISATION USING RIETVELD X-RAY AND NEUTRON POWDER DIF
METROLOGICAL ASSURANCE OF QUALITY CONTROL OF PHARMACEUTICAL PRODUCTION
MICRO-SAMPLE X-RAY POWDER DIFFRACTION. APPLICATIONS IN THE PHARMACEUTI
MISCELLANEOUS PRACTICAL ISSUES FOR PXRD IN A QC LABORATORY
MONOPOTASSIUM DIHYDROGEN CITRATES
NANOSTRUCTURE ANALYSIS OF PHARMACEUTICAL APPLICATIONS USING 2D SMALL A
NEUTRON POWDER DIFFRACTION WITHOUT RESORT TO DEUTERATION: USE IN MOLEC
NEW DETECTOR TECHNOLOGY FOR SUPER SPEED X-RAY DIFFRACTION
NEW DEVELOPMENTS IN LABORATORY X-RAY NANOANALYTICS FOR PHARMAZEUTICAL
NEW POLYMORPH SCREENING APPROACHES
NEW POSSIBILITIES FOR X-RAY DIFFRACTOMETRY
NON-AMBIENT CONDITIONS X-RAY POWDER DIFFRACTION IN PHARMACEUTICAL INDU
NON-INVASIVE X-RAY POWDER DIFFRACTION QUANTITATION OF GLYCINE POLYMORP
PARTICLE SIZE ANALYSIS BY TWO-DIMENSIONAL XRD
PARTICLE STATISTICS ENHANCEMENT FOR XRD ANALYSIS USING VIBRATING SAMPL
PAT: ANALYSIS OF PROCESS INDUCED DISORDER OF API BY X-RAY POWDER DIFFR
PATENT AND REGULATORY ISSUES - THE EUROPEAN PERSPECTIVE
PATENT LITIGATION AND X-RAY POWDER DIFFRACTION:SWIMMING WITH THE SHARK
PATENTING CRYSTALLINE FORMS OF PHARMACEUTICALS USING SOLID STATE SCI
PDF-4/ORGANICS 2006 REFERENCE POWDER PATTERNS AND THEIR PHARMACEUTICAL
PHARMACEUTICAL POWDER DIFFRACTION: MAKING MOVIES
PHARMACEUTICAL POWDER X-RAY DIFFRACTION: FROM DESIGN TO FINAL SELECTIO
PHARMACEUTICAL REFERENCE APPLICATIONS OF PDF-4/ORGANICS 2008
PHARMACEUTICAL ROUND ROBIN FOR QUANTITATIVE PHASE ANALYSES
PHARMACEUTICAL SOLID POLYMORPHISM THE FDA VIEW
PHARMACEUTICAL SOLID-STATE CHARACTERIZATION BY SIMULTANEOUS SMALL-AND
PHYSICAL STABILITY OF AMORPHOUS SOLID DISPERSIONS: XRPD AND COMPUTATIO
POLYCAPILLARY X-RAY OPTICS ENABLED DIFFRACTION-BASED PROCESS DIAGNOSTI
POLYMORPH ANALYSES: TOOLS AND RESULTS
POLYMORPH SCREENING: A COMPARISON BETWEEN XRPD AND COMPLEMENTARY TECHN
POLYMORPHIC ANALYSIS OF TEGAFUR
POLYMORPHIC FORM SCREENING USING X-RAY POWDER DIFFRACTION
POLYMORPHISM AND DRUG DEVELOPMENT:A REGULATOR'S VIEWPOINT
POLYMORPHS AND OTHER CRYSTAL FORMS: WHAT\'S IN THAT POWDER?
POLYMORPHS AND PURITY AND PATENTS; OH MY.
POLYMORPHS IN PDF-4/ORGANICS 2010
POWDER DIFFRACTION AND CRYSTAL STRUCTURE PREDICTION: A TWO-WAY RELATIO
POWDER DIFFRACTION METHODS IN MACROMOLECULAR CRYSTALLOGRAPHY
POWDER DIFFRACTION STUDIES OF POLYCRYSTALLINE PROTEIN
POWDER DIFFRACTION USING SYNCHROTRON SOURCES FOR PHARMACEUTICAL PROBLE
POWDER PATTERN INDEXING
POWDER X-RAY DIFFRACTION IN THE RANGE 2 THETA < 15 (LAMBDA = 0.154
PRACTICAL IMPLICATIONS OF SOLID STATE ATTRIBUTES DURING DRUG DISCOVERY
PREPARATION AND CHARACTERISATION OF GLIMEPIRIDE SOLID DISPERSIONS BY P
PRINCIPLES IN CLAIMING AND ENFORCING SOLID FORM PATENTS
PROSECUTING AND LITIGATING PXRD PATENTS
PROTEIN MEASUREMENT ON LABORATORY POWDER DIFFRACTOMETER
PROTEIN POWDER DIFFRACTION AT THE ESRF
PXRD ANALYSIS OF THE MECHANICALLY INDUCED INTER-CONVERSION BETWEEN TWO
PXRD INVESTIGATION OF CHANGES IN DEHYDRATION BEHAVIOR OF 7-METHOXY-1-M
PXRD WITH RAMAN SPECTROSCOPY, DSC AND IR DATA
QUANTIFICATION OF INDOMETHACIN-SACCHARIN COCRYSTALS BY POWDER X-RAY DI
QUANTITATIVE ANALYSIS OF MIXTURES USING HIGH THROUGHPUT INSTRUMENTATIO
QUANTITATIVE ANALYSIS OF PHASES WITH PARTIAL OR NO KNOWN CRYSTAL STRUC
QUANTITATIVE EVALUATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT IN TABL
QUANTITATIVE MULTIVARIATE APPLICATIONS IN PXRD OF INTACT MULTI-COMPONE
QUANTITATIVE PHASE ANALYSIS OF ISOTIBOLONE IN TIBOLONE RAW MATERIAL US
QUANTITATIVE PHASE ANALYSIS OF PHARMACEUTICAL COMPOUNDS BY THE WHOLE-P
QUANTITATIVE POLYMORPH ANALYSIS IN DRUG PRODUCT BY XRD
QUESTION-BASED REVIEW - LINKING REGULATORY EVALUATION OF SOLID STATE P
RAPID COMBINATORIAL SCREENING BY TWO-DIMENSIONAL XRD
RE-EXAMINING STRUCTURE AND CRYSTALLINITY IN CELLULOSE
RECENT ADVANCES IN STRUCTURE SOLUTION FROM POWDER DIFFRACTION DATA
RESOLVING POLYMORPH CHEMISTRY IN THE CA-O-P-H SYSTEM
RIETVELD STRUCTURAL AND MICROSTRUCTURAL CHARACTERIZATION OF PHARMACEUT
ROUND ROBIN FOR PHARMACEUTICAL COMPOUNDS
ROUND ROBIN FOR PHARMACEUTICAL X-RAY POWDER DIFFRACTION
SAMPLES FOR ROUND ROBIN
SAXSESS - AN ANALYTICAL TOOL FOR BIOMATERIALS
SAXSESS A TOOL FOR PHARMACEUTICAL MATERIALS
SCREENING FOR SOLID-STATE TRANSFORMATIONS DURING SALT SELECTION
SDPD: A KEY COMPONENT IN POPULATING THE CARBAMAZEPINE CRYSTAL STRUCTUR
SIMULATED PXRD PATTERNS AS STANDARD REFERENCES IN PHARMACEUTICAL FORM
SIMULATED PXRD PATTERNS IN STUDIES OF THE PHASE COMPOSITION AND THERMA
SINGLE CRYSTAL STUDIES OF MEFENAMIC ACID AS A TOOL TO UNDERSTAND POLYM
SMALL-AND WIDE-ANGLE X-RAY SCATTERING IN PHARMACEUTICAL RESEARCH AND I
SOLID STATE CHARACTERIZATION OF A POTENTIALLY ACTIVE BENZOTHIAZOL DERI
SOLID-STATE ANALYSIS OF PHARMACEUTICALS: SOLID-STATE NMR AND PXRD
SOLID-STATE TRANSITIONS OF PHARMACEUTICAL COMPOUNDS STUDIED BY POWDER
SOLVING CRYSTAL STRUCTURES WITH MOLECULAR ORIENTATIONAL DISORDER USING
SOLVING ORGANIC STRUCTURES FROM POWDER DATA AT LOW RESOLUTION USING CH
STRUCTURAL DSC EXPLOITING TIME-RESOLVED POWDER DIFFRACTION
STRUCTURE ANALYSIS FROM POWDER DIFFRACTION DATA SUPPORTED BY TOTAL ENE
STRUCTURE DETERMINATION OF A NEW POLYMORPH OF RACEMIC IBUPROFEN FROM L
STRUCTURE DETERMINATION OF AMBUIC ACID WITH SYNCHROTRON POWDER DIFFRAC
STRUCTURE DETERMINATION OF CAFFEINE ANHYDROUS C8H10N4O2 FROM POWDER DI
STRUCTURE SOLUTION AND QUANTITATIVE X-RAY POWDER DIFFRACTION OF PHARMA
STRUCTURE STUDIES OF DISORDERED PHARMACEUTICAL MATERIALS BY HIGH-ENERG
STRUCTURES AND TRANSFORMATIONS IN PHARMACEUTICALS
STUDYING AMORPHOUS PHARMACEUTICAL MATERIALS BY POWDER X-RAY DIFFRACTIO
STUDYING STRUCTURAL ASPECTS OF SALT HYDRATION BY VT-PXRD
SUCCESSFUL MATERIAL IDENTIFICATION
SYNCHROTRON X-RAY POWDER DIFFRACTION: APPLICATIONS IN MACROMOLECULAR C
THE AMORPHOUS STATE: A STRUCTURAL PERSPECTIVE
THE ANALYSIS OF NANOMATERIALS, AMORPHOUS MATERIALS AND SEMICRYSTALLINE
THE APPLICATION OF SMALL-ANGLE SCATTERING TECHNIQUES IN THE DESIGN AND
THE CRYSTAL STRUCTURE OF GUAIFENESIN, 3-(2-METHOXYPHENOXY)-1,2-PROPANE
THE ELUCIDATION OF THE TETRAMORPHISM OF FANANSERINE WITH XRPD:FROM PHA
THE EUROPEAN XRPD STANDARD AND ITS RELEVANCE TO THE PRACTITIONER
THE NEW GOLDEN AGE OF PHARMACEUTICAL PATENTS: COCRYSTALS AND THE SOLID
THE NEW ORGANIC POWDER DIFFRACTION FILE, PDF-4/ORGANIC 2002, WITH INTE
THE NEW WORLD OF MATERIALS SCIENCE & ENGINEERING: NANO & BIO T
THE ROLE OF PXRD IN QBD AND PAT
THE SEARCH FOR POLYMORPHS AND SALTS USING HIGH THROUGHPUT POWDER DIFFR
THE STUDY OF RIGID JOINT THERAY USING DRY BONE OF PITHUOPHIS MELANOLEU
THE STUDY ON THE STABILITY OF A DRUG. CAN A PRODUCT HAVE LIFE?
THE USE OF FIELD-PORTABLE PXRD FOR THE RAPID IDENTIFICATION OF COUNTER
THERMAL BEHAVIOUR OF AZITHROMYCIN MONOHYDRATE AND DIHYDRATE FORMS
TOWARD A RATIONALIZATION OF THE HYDRATION-DEHYDRATION MECHANISM OF SOD
TRANSFORMATIONS AND CRYSTAL STRUCTURES OF A SUBSTITUED TRIAZINE AND IT
TRENDS IN SOLID FORM PATENTS: COCRYSTAL IP OPPORTUNITIES AND CHALLENGE
TWO POSSIBLE VARIANTS OF A SINGLE CRYSTAL FORM OF AN API AND HOW TO FI
TWO-DIMENSIONAL XRD FOR PHARMACEUTICAL
USAGE OF AN ADVANCED FULLPAT METHOD TO QUANTIFY AMORPHOUS MATERIAL
USE OF FUNDAMENTAL PARAMETER APPROACH IN PHARMACEUTICAL METHOD DEVELOP
USE OF X-RAY POWDER DIFFRACTOMETRY IN DRUG DISCOVERY, PREFORMULATION A
USE OF X-RAY POWDER DIFFRACTOMETRY TO MONITOR PHASE TRANSITIONS DURING
USING ANALYTICAL DATA MANAGEMENT SYSTEMS TO ACCELERATE SALT AND POLYMO
USING POWDER X-RAY DIFFRACTION ANALYSIS FOR A PHARMACEUTICAL NANOCOMPO
VALIDATING CRYSTAL STRUCTURES SOLVED FROM POWDER DIFFRACTION DATA USIN
WATCHING THE ACTION AND GETTING THE MOST FROM YOUR DATA
WHAT IS IN YOUR PILL? WHAT ABOUT THEIRS?
WHEN KEEN OBSERVATION SAVES YOU MONEY
WWW.POWDERDATA.INFO: A RELIABLE SOURCE OF FREELY AVAILABLE, HIGH-QUALI
X-RAY DIFFRACTION ANALYSIS OF COCRYSTALS EXHIBITING A DISORDERED GUEST
X-RAY DIFFRACTION AND COMPLEMENTARY ANALYTICAL TECHNIQUES INCLUDING MI
X-RAY DIFFRACTION APPLIED TO DRUG DEVELOPMENT AN OVERVIEW
X-RAY POWDER DIFFRACTION (XRPD) LIKE TOOL IN THE CHARACTERIZATION OF S
X-RAY POWDER DIFFRACTION AND SORPTION-DESORPTION INVESTIGATIONS OF IND
X-RAY POWDER DIFFRACTION AT THE HEART OF PHYSICAL FORM DISCOVERY IN CP
X-RAY POWDER DIFFRACTION DATABASE TOOLS FOR THE PHARMACEUTICAL SCIENTI
X-RAY POWDER DIFFRACTION IN QUANTIFYING POLYMORPHIC MIXTURES OF PHARMA
X-RAY POWDER DIFFRACTION PATTERN OF IMIPENEM MONOHYDRATE
X-RAY SCATTERING STUDIES ON NANO CRYSTALLINE AND AMORPHOUS MATERIALS U
X-RAY SOURCE, OPTICS AND DETECTORS FOR PHARMACEUTICAL XRD
XPRD, EXAFS, AND SAXS FOR CHARACTERIZATION OF NANOPARTICLES FOR PHARMA
XRD CHARACTERIZATION OF CRYSTALLINITY AND MICROSTRUCTURE OF PHARMACEUT
XRD COMBINATORIAL SCREENING SYSTEM WITH AUTOMATED REFLECTION-TRANSMISS
XRPD CHARACTERISATION OF PHARMACEUTICAL SOLIDS - QUANTITATIVE PHASE AN
XRPD FOR NONDESTRUCTIVE CHARACTERIZATION OF SOLID DOSAGE FORMS
XRPD PATTERN MATCHING: PROBABILITY BASED VERSUS IMAGE COMPARISON
Search Text-String in Titles and Authors
Search tips
:
Double quotes("") searches for the exact phrase i.e. "structure diffraction".
Boolean operators (and, or) can be used to expand or limit your searches.
Search Text-String in Articles
Search tips
:
Double quotes("") searches for the exact phrase i.e. "diffraction data".
Boolean operators (and, or) can be used to expand or limit your searches.